UBS Group »

Supernus Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 65k 28.94
2023-09-30 $525k 19k 27.57
2023-06-30 $1.6M 54k 30.05
2023-03-31 $1.4M 40k 36.23
2022-12-31 $1.0M 28k 35.67
2022-09-30 $258k 7.5k 34.17
2022-06-30 $45k 1.6k 28.38
2022-03-31 $2.6M 84k 30.61
2021-12-31 $2.9M 99k 29.02
2021-09-30 $82k 3.0k 26.74
2021-06-30 $744k 24k 30.83
2021-03-31 $4.6M 175k 26.18
2020-12-31 $4.6M 181k 25.16
2020-09-30 $351k 17k 20.93
2020-06-30 $707k 30k 23.79
2020-03-31 $734k 41k 17.98
2019-12-31 $1.3M 54k 23.73
2019-09-30 $4.5M 163k 27.48
2019-06-30 $23M 696k 33.09
2019-03-31 $23M 676k 34.56
2018-12-31 $12M 351k 33.23
2018-09-30 $16M 323k 50.31
2018-06-30 $1.8M 30k 59.86
2018-03-31 $657k 14k 45.80
2017-12-31 $548k 14k 40.00
2017-09-30 $1.8M 45k 40.00
2017-06-30 $2.6M 61k 43.10
2017-03-31 $1.9M 61k 31.31
2016-12-31 $505k 20k 25.24
2016-09-30 $685k 28k 24.72
2016-06-30 $93k 4.5k 20.67
2016-03-31 $69k 4.5k 15.33
2015-12-31 $698k 52k 13.44
2015-09-30 $705k 50k 14.04
2015-03-31 $544k 45k 12.18